Multicentric Castleman disease is a rare condition that causes inflammation and enlarged lymph nodes in more than one area of the body. Early symptoms of multicentric Castleman disease can include fever, night sweats, tiredness, weight loss, and swelling in the neck, armpits, or groin. It most often affects adults, and it can last for months or longer without treatment. Not everyone will have the same experience. Multicentric Castleman disease can be serious and sometimes life threatening, but treatment such as medicines that block inflammation, antiviral treatment in some cases, chemotherapy, and supportive care can help many people.
How many people live with Multicentric castleman disease?
Worldwide, there is no single trusted recent estimate for how many people are living with multicentric Castleman disease. In the United States, widely cited estimates suggest about 4,000 to 5,000 people are living with it (Castleman Disease Collaborative Network, 2024).
Overview
Multicentric castleman diseaseSymptoms
Multicentric Castleman disease often causes swollen lymph nodes, fevers, night sweats, and severe tiredness. Many also have weight loss, poor appetite, or swelling from fluid buildup.
Outlook and prognosis
With multicentric Castleman disease, outlook varies by cause, organ involvement, and how well treatment controls flares. Many people living with multicentric Castleman disease do better with ongoing specialist care, but some may face relapses or serious complications.
Causes and risk factors
Multicentric Castleman disease can be linked to HHV-8 infection, especially in people living with HIV. Some cases have no clear cause and may involve immune system overactivity. Risk is higher with immune suppression, while lifestyle factors are not known primary causes.
Genetic influences
Genetics do not seem to be the main driver of multicentric Castleman disease in most people. It is usually not inherited, and no single gene change explains most cases, though rare genetic variations may affect immune signaling in some people.
Diagnosis
Doctors diagnose multicentric Castleman disease using swollen lymph nodes, blood tests, imaging, and a lymph node biopsy. Because other illnesses can look similar, ruling out infection, autoimmune disease, and lymphoma is also part of diagnosis.
Treatment and drugs
Multicentric Castleman disease is usually treated with medicines that calm the overactive immune system, especially drugs that block IL-6. Some people also need steroids, rituximab, or chemotherapy. Care often includes treating infections, fluid buildup, and low blood counts.
Symptoms
Multicentric Castleman disease often makes people feel generally unwell, as if the body is fighting something it cannot settle. Common problems include fevers, drenching night sweats, severe tiredness, weight loss, and swollen lymph nodes in more than one area. The early symptoms of multicentric Castleman disease can look a lot like infection or another inflammatory illness, which is one reason diagnosis can take time. Symptoms vary from person to person and can change over time.
Multicentric Castleman disease often causes lymph nodes to enlarge in more than one part of the body, such as the neck, underarms, groin, chest, or belly. Some people feel tender lumps, while others notice pressure or fullness instead.
Ongoing fevers and drenching night sweats are common and may come in flares. You may wake up soaked, feel chilled and achy, or seem to have a stubborn flu-like illness that keeps returning.
Tiredness in multicentric Castleman disease can be intense and may not improve much with rest. Everyday tasks like climbing stairs, shopping, or getting through a workday can start to take much more effort.
Unplanned weight loss often happens along with a poor appetite. Some people feel full quickly, feel mildly nauseated, or simply do not feel like eating very much.
How people usually first notice Multicentric castleman disease?
Multicentric Castleman disease is often first noticed when someone feels unusually unwell in a broad, hard-to-pin-down way: fevers that keep coming back, drenching night sweats, deep fatigue, unplanned weight loss, or a sense that their body is under strain. Many people with multicentric Castleman disease also notice swollen lymph nodes, often in the neck, armpits, or groin, and some develop belly fullness, shortness of breath, swelling in the legs, or easy bruising as inflammation affects more than one part of the body. Because these first signs of multicentric Castleman disease can look like an infection, an autoimmune illness, or even stress at first, it is usually recognized only after symptoms persist, worsen, or show up alongside abnormal blood tests and enlarged lymph nodes on an exam or scan.
Types of Multicentric castleman disease
Multicentric Castleman disease can look quite different from one person to the next, even though it affects lymph nodes and can cause whole-body inflammation. In practice, the main types of multicentric Castleman disease are grouped by what is driving the illness, and that often shapes how symptoms show up and how severe they become. Symptoms don’t always look the same for everyone. Some people mainly deal with fevers, drenching night sweats, and swollen lymph nodes, while others have more fluid buildup, nerve problems, or low blood counts.
HHV-8-associated
This type is linked to human herpesvirus 8 and is more common in people with a weakened immune system, especially those living with HIV. Symptoms often come on with fever, fatigue, weight loss, enlarged lymph nodes, and an enlarged liver or spleen. Some may also have fluid buildup, low blood counts, or repeated flare-ups that make daily life harder.
Idiopathic MCD
In this form, no clear viral cause is found, which is why it is called idiopathic multicentric Castleman disease. Many living with this type have swollen lymph nodes, fevers, night sweats, tiredness, weight loss, and abnormal blood test results linked to inflammation. The balance of symptoms can shift over time, and severity can range from mild to life-threatening.
TAFRO subtype
This is a recognized clinical variant of idiopathic multicentric Castleman disease marked by low platelets, body-wide swelling, fever, kidney problems, and enlarged organs. People with TAFRO subtype may become sick quite quickly, sometimes over days to weeks rather than months. Compared with other types of multicentric Castleman disease, swollen lymph nodes may be less striking while fluid retention and weakness are more prominent.
iMCD-NOS
This term means idiopathic multicentric Castleman disease not otherwise specified, covering cases that do not fit the TAFRO pattern. Symptoms often include enlarged lymph nodes, fevers, night sweats, weight loss, and high inflammation, and some people also develop too few red blood cells. Among the variants of multicentric Castleman disease, this group is often more mixed in how symptoms appear and how fast they progress.
POEMS-associated
This rare type occurs in people who also have POEMS syndrome, a disorder linked to abnormal plasma cells. Along with swollen lymph nodes, people may notice nerve symptoms such as numbness or weakness, hormone problems, skin changes, and fluid buildup. One person might struggle mostly with tingling and leg weakness, while another notices more swelling and fatigue.
Can I slow down the onset of symptoms?
Probably not in a reliable way: there is no strong evidence that diet, exercise, supplements, or other lifestyle changes can meaningfully delay the start of multicentric Castleman disease symptoms. Some cases are linked to HIV and another virus, so for people living with HIV, staying in regular care and taking HIV treatment as prescribed may lower the risk of that form, but for many others the cause is not something you can change and research on prevention is still limited. Healthy habits still support overall health, but they should be seen as general support rather than a way to prevent this disease, and getting checked early for swollen glands, fevers, night sweats, or unusual tiredness can still make a real difference.
What genetics can tell you about symptoms
For most people living with multicentric Castleman disease, genetics does not clearly predict which symptoms will happen, how severe they will be, or exactly when they will start. Unlike some inherited conditions, this disease is usually not passed down in families, and symptoms are more strongly linked to inflammation and, in some cases, infection with human herpesvirus 8 rather than a known inherited gene change. Researchers are studying whether certain genetic differences may affect how the immune system behaves in some people, but this is not yet reliable enough to use for symptom prediction in routine care.
Causes and risk factors
Multicentric Castleman disease often develops when the immune system becomes overactive and releases too many signals that drive inflammation, sometimes because of a virus called HHV-8. One of the main risk factors for multicentric Castleman disease is having HIV or another weakened immune system. In other cases, the exact cause is not clear, but abnormal immune activity and some infections may play a role. Researchers are still learning how these pieces fit together. There is no strong proof that multicentric Castleman disease is inherited or caused by everyday habits, but factors that increase the chance of HIV infection can indirectly raise risk.
What are the most common causes or risk factors?
The best-known cause of multicentric Castleman disease is infection with a virus called human herpesvirus-8 (HHV-8), and the risk is much higher in people with HIV or another weakened immune system. Many others develop it without a clear cause; in these cases, the body’s defense system seems to become overactive and make too many inflammation signals. Inherited genetic risk does not appear to be a common cause, and most people living with this condition do not have a family history of it.
Environmental and biological risk factors
Multicentric Castleman disease is rare, and the main risk factors for multicentric Castleman disease are mostly biological rather than environmental. Doctors often group risks into internal (biological) and external (environmental). The strongest links involve HHV-8 infection, HIV, and conditions that weaken immune defenses. Some cases happen without a clear trigger, so not everyone who develops multicentric Castleman disease has an obvious risk factor.
Infection with human herpesvirus 8, often shortened to HHV-8, is one of the strongest known biological risk factors for multicentric Castleman disease. The virus can overstimulate the immune system and help drive the abnormal lymph node changes seen in this illness.
HIV greatly raises the chance of HHV-8-related multicentric Castleman disease, especially when immune defenses are weaker. Many people with HIV never develop it, but the risk is clearly higher than in people without HIV.
A weakened immune system can make it easier for HHV-8 to reactivate and contribute to multicentric Castleman disease. This can happen with advanced HIV or with medicines that suppress immunity after an organ transplant.
Some people develop multicentric Castleman disease alongside POEMS syndrome, a rare disorder that affects the blood, nerves, and other body systems. This is not a common risk in the general public, but it is a recognized biological link.
Genetic risk factors
Multicentric Castleman disease does not usually have a clear inherited genetic cause. Unlike disorders caused by one changed gene, MCD rarely runs in families. It’s usually a combination of influences rather than one clear cause. Researchers are studying rare DNA changes in immune cells, but no common inherited genetic risk factor has been firmly established.
Inherited mutations: No single inherited gene has been proven to cause multicentric Castleman disease in most people. For many living with MCD, genetic testing does not find a clear passed-down explanation.
Family history: Multicentric Castleman disease rarely affects several relatives in the same family. When families ask whether multicentric Castleman disease is hereditary, the answer is usually no.
Acquired DNA changes: Some studies suggest that DNA changes acquired during life in certain immune cells may help drive disease in a small number of people. These changes are not the same as inherited mutations and are not yet a routine finding.
Immune-related genes: Researchers are investigating genes that control inflammation because the illness often involves overactive immune signaling. So far, this has not led to a standard genetic marker that can reliably predict who will get MCD.
Lifestyle risk factors
Multicentric Castleman disease is not known to be caused by lifestyle habits, and there are no proven lifestyle risk factors that trigger the disease itself. Still, how lifestyle affects multicentric Castleman disease can matter because daily habits may influence inflammation, infection risk, treatment tolerance, fatigue, and recovery. The most useful focus is on behaviors that can worsen symptoms or raise the chance of complications during treatment.
Smoking can worsen lung irritation, reduce exercise tolerance, and make infections or breathing problems harder to recover from during multicentric Castleman disease. It may also increase strain on the heart and blood vessels when the disease or its treatment already causes systemic stress.
Heavy alcohol use can impair liver function, worsen dehydration, and interfere with recovery if you are dealing with fevers, poor appetite, or weight loss. It can also complicate the safe use of medicines used to treat multicentric Castleman disease.
Undereating, low protein intake, or a very unbalanced diet can worsen weakness, muscle loss, and delayed recovery in people with multicentric Castleman disease. During active illness or treatment, poor nutrition may also make it harder for the body to cope with inflammation and infection.
Too little physical activity can lead to deconditioning, more fatigue, and loss of muscle strength, which may make day-to-day symptoms feel worse. Gentle, individualized movement may help preserve stamina and function when symptoms are stable enough for exercise.
Risk prevention
For most people, there is no sure way to prevent multicentric Castleman disease because it is a rare condition that often develops for reasons outside your control. Prevention is more realistic for some virus-linked cases, especially those related to HIV and human herpesvirus 8, and for reducing complications after diagnosis. Prevention is about lowering risk, not eliminating it completely. If you are worried because of immune problems or new swollen lymph nodes, fevers, or weight loss, it is worth discussing the early symptoms of multicentric Castleman disease with a doctor.
Lowering the chance of HIV infection can also lower the risk of HIV-associated multicentric Castleman disease. Safer sex, not sharing needles, and access to HIV prevention tools such as pre-exposure prophylaxis can help.
For people living with HIV, staying on effective treatment helps support the immune system and may reduce complications linked to multicentric Castleman disease. Regular HIV care also helps doctors pick up concerning changes earlier.
Avoiding unnecessary immune suppression and managing conditions that weaken immunity may help reduce risk in some people. This matters most because multicentric Castleman disease is more common when immune defenses are impaired.
Early medical review for ongoing fevers, drenching night sweats, unusual tiredness, weight loss, or enlarged lymph nodes may lead to faster diagnosis and treatment. While this does not prevent multicentric Castleman disease itself, it can help prevent severe organ stress and other complications.
Can you prevent Multicentric castleman disease?
Multicentric Castleman disease usually cannot be prevented because doctors often do not know exactly why it starts. In some people, it is linked to HIV or other problems that weaken the immune system, so lowering the risk of HIV and getting good treatment if you have it may reduce the chance of this type, but it cannot guarantee prevention.
Transmission
Multicentric Castleman disease is usually not something you can catch from someone else. Many people ask whether Multicentric Castleman disease can spread from person to person, and the answer is no: the condition itself is not considered contagious.
In some people, Multicentric Castleman disease is linked to a virus called human herpesvirus 8, which can pass through body fluids, especially in people with weakened immune systems. Even then, having the virus does not mean someone will develop Multicentric Castleman disease, so the condition itself is not thought to be highly infectious.
When to test your genes
For multicentric Castleman disease, routine inherited gene testing is usually not recommended, because it is not generally an inherited condition and there is no standard genetic screen for early detection. Genetic testing may be considered if your symptoms suggest another immune, inflammatory, or cancer-related disorder, or in complex cases at a specialist center.
Diagnosis
Multicentric Castleman disease is usually diagnosed after a pattern of ongoing symptoms and abnormal test results starts to come together, rather than from one single finding. Many living with multicentric Castleman disease have swollen lymph nodes, fevers, night sweats, tiredness, weight loss, or fluid buildup that first lead to medical evaluation. Doctors usually begin with an exam and a review of symptoms to work out how multicentric Castleman disease is diagnosed and to look for other illnesses that can cause similar problems.
Your doctor asks about symptoms, when they started, and whether they come and go or keep getting worse. They also ask about infections, immune problems, medicines, and other conditions that could mimic multicentric Castleman disease.
The exam often focuses on enlarged lymph nodes in the neck, armpits, or groin, along with swelling in the legs or belly. Doctors also look for fever, enlarged liver or spleen, skin changes, or signs of fluid around the lungs.
Blood tests can show inflammation, anemia, low albumin, kidney problems, or changes in platelets and other blood cells. These results do not prove multicentric Castleman disease on their own, but they help support the diagnosis and rule out common causes.
Doctors often test for HIV and human herpesvirus 8, also called HHV-8, because these infections can be linked to some cases. Knowing whether HHV-8 is present helps guide the type of multicentric Castleman disease and the best treatment plan.
How is Multicentric castleman disease diagnosed?
Multicentric Castleman disease is usually diagnosed by putting together several clues: symptoms, a physical exam, blood tests that show inflammation or low blood counts, and scans such as CT or PET to look for swollen lymph nodes and affected organs. The most important step is often a biopsy, where a doctor removes part or all of a lymph node and checks it under a microscope, because this helps tell it apart from infections, immune system conditions, and cancers like lymphoma. Doctors may also test for viruses linked to some cases, especially HIV and a virus called HHV-8, since that can affect the diagnosis and treatment plan.
Stages of Multicentric castleman disease
Multicentric castleman disease does not have defined progression stages. That is because it is usually understood by how active and widespread the inflammation is at a given time, rather than by a steady step-by-step decline from one stage to the next. Doctors usually start with a conversation about symptoms such as fevers, night sweats, tiredness, weight loss, and enlarged lymph nodes, since early symptoms of multicentric castleman disease can look like other illnesses. Diagnosis and follow-up usually rely on a mix of blood tests, imaging scans, and often a lymph node biopsy to confirm the cause and monitor how active the disease is.
Outlook and prognosis
The outlook for multicentric Castleman disease varies widely and depends on the subtype, severity of inflammation, organ involvement, and how quickly effective treatment is started. Idiopathic multicentric Castleman disease can range from a relapsing chronic illness to a life-threatening condition, but many patients improve substantially with modern therapies such as anti-IL-6 treatment and careful supportive care. HHV-8-associated multicentric Castleman disease often has a more serious course, especially in people with HIV or other causes of immune suppression, although outcomes have improved markedly with antiretroviral therapy and rituximab-based treatment. Potentially fatal complications include severe infections, multiorgan failure, thrombotic events, and progression to lymphoma or other malignancies in some patients. Mortality is still possible, particularly in aggressive or treatment-resistant disease, but survival has improved in recent years as diagnosis and targeted therapy have become more effective.
Long-term effects
Many living with multicentric Castleman disease deal with periods of relative stability mixed with flares, so the long-term picture can be uneven. Long-term effects vary widely, depending on the subtype, how active the inflammation is, and how well treatment controls it. Even when challenges remain, many people continue to do well for years with close follow-up and the right treatment plan.
Multicentric Castleman disease can come back in cycles, with symptoms improving and then worsening again over time. These flares may bring back swollen lymph nodes, fevers, night sweats, weight loss, or profound tiredness.
Persistent inflammation can leave many people feeling drained even between major flares. For many, this can mean getting through work, exercise, or routine errands feels harder than it used to.
Long-term inflammation may lead to anemia, which can cause weakness, shortness of breath, and poor stamina. Some people with multicentric Castleman disease also develop low or high platelet counts, which can raise the risk of bleeding or clotting problems.
When inflammation stays active, it can affect organs such as the liver, kidneys, or lungs. Over time, this may cause fluid buildup, abnormal blood tests, breathing problems, or reduced organ function.
How is it to live with Multicentric castleman disease?
Living with multicentric Castleman disease can feel unpredictable because symptoms often come in waves: one week you may manage fairly well, and the next you may be dealing with profound fatigue, fevers, night sweats, swollen lymph nodes, poor appetite, or trouble keeping up with work, school, and daily routines. For many people with multicentric Castleman disease, daily life also includes regular blood tests, scans, clinic visits, and treatment schedules, plus the emotional strain of living with a rare illness that can flare and require urgent care. The effects reach beyond the person who has it, because family and friends may take on driving, caregiving, financial, or household responsibilities, yet with specialist care, practical support, and a flexible routine, many living with multicentric Castleman disease find ways to protect quality of life and plan around the disease rather than let it define every day.
Treatment and drugs
Multicentric Castleman disease is usually treated with medicines that calm the overactive immune system, because the illness can cause ongoing fatigue, fevers, swollen lymph nodes, and other symptoms that affect daily life. Treatment often looks different for each person, but many people with Multicentric Castleman disease receive targeted drug treatment, especially medicines that block a body signal called interleukin-6, which helps drive inflammation in many cases. If that does not work well enough, doctors may use other treatments such as corticosteroids, chemotherapy, antiviral treatment when a related virus is present, or drugs that lower immune activity. Because early symptoms of Multicentric Castleman disease can overlap with other illnesses, care is often guided by a blood specialist and adjusted over time based on symptoms, blood tests, and the underlying subtype.
Can you cure Multicentric castleman disease?
No, there is not a reliable cure for multicentric Castleman disease at this time. The good news is that treatment can often control the disease, ease symptoms, and sometimes keep it quiet for long periods. Depending on the cause, doctors may use medicines that calm the overactive immune system, treat a related virus, or, in some cases, use cancer-type drug treatment.
Non-drug treatment
Living with multicentric Castleman disease can mean coping with severe fatigue, swelling, fevers, and the stop-and-start rhythm of flare-ups and recovery. Most people need medical treatment, but non-drug care can still make day-to-day life safer and more manageable. Managing this condition often includes supportive care to help with strength, nutrition, comfort, and monitoring between treatments. For many, supportive care for multicentric Castleman disease is an important part of staying as well as possible.
Eating enough can be hard when multicentric Castleman disease causes poor appetite, nausea, or early fullness. A dietitian can help with small frequent meals, higher-protein foods, and fluids so energy and weight are easier to maintain.
Gentle exercise and physical therapy can help rebuild stamina, muscle strength, and balance after time spent feeling unwell. Some may find that short walks or supervised movement sessions make everyday tasks, like climbing stairs or shopping, feel less draining.
Fatigue is one of the most common symptoms, so pacing activities and planning rest breaks can help conserve energy. Simple routines—like regular sleep times or brief daytime rests—can have lasting benefits.
Counseling, support groups, or stress-management skills can help people cope with uncertainty, repeated appointments, and the emotional strain of chronic illness. Not every approach works the same way, so some people do best with one-on-one therapy while others prefer group support.
Your genes may have an impact on how drugs work for you
For people with multicentric Castleman disease, inherited differences in genes can sometimes change how the body breaks down certain medicines, which may affect side effects or how strong a dose is needed. In day-to-day care, though, this is usually not the main reason one treatment works better than another; doctors more often base treatment on the type of Castleman disease, whether a virus is involved, and how sick someone is overall. So while genes can play a small role, genetic testing to match medicines is not yet a routine part of treatment for most people living with this condition.
Pharmacological treatments
Treatment for multicentric Castleman disease depends on what is driving the illness, how severe it is, and whether it is linked to HHV-8 or HIV. Many people find relief when the right medicine is matched to their subtype and symptoms, but treatment often needs careful follow-up and adjustment. Some drugs calm the immune signals causing inflammation, while others target abnormal immune cells more directly. In severe flares, doctors may combine medicines to bring swelling, fever, fatigue, and organ problems under control more quickly.
Siltuximab is a targeted antibody drug that blocks interleukin-6, a key inflammation signal in many people with idiopathic multicentric Castleman disease. It is often the first approved treatment for multicentric Castleman disease when HHV-8 and HIV are not the main cause.
Tocilizumab also targets the interleukin-6 pathway, but it blocks the receptor rather than the signal itself. It may be used when siltuximab is not available, is not suitable, or has not worked well enough.
Rituximab targets B cells, a type of immune cell that can help drive multicentric Castleman disease, especially in HHV-8-associated disease. It is commonly used alone or with other treatments, particularly for people living with HIV or HHV-8 infection.
Prednisone or methylprednisolone can reduce inflammation quickly and may help during a sudden worsening of symptoms. These medicines are usually used short term because symptoms often return if steroids are used alone.
Genetic influences
Many people ask whether multicentric Castleman disease is hereditary. It’s natural to ask whether family history plays a role. In most cases, multicentric Castleman disease is not considered an inherited condition passed from parent to child, and it usually does not run strongly in families. Instead, it is more often linked to abnormal immune system signaling and, in some people, to infection with human herpesvirus 8 (HHV-8), rather than to a single gene change present from birth. Researchers are still studying whether acquired gene changes in certain immune cells may contribute in some cases, but this is not yet a routine part of diagnosis or treatment for most people with multicentric Castleman disease. For many living with multicentric Castleman disease, family history is usually less important than the immune and infection-related factors their medical team looks for.
Is Multicentric castleman disease genetic?
Genetics do not seem to be the main driver of multicentric Castleman disease in most people. It is usually not inherited, and no single gene change explains most cases, though rare genetic variations may affect immune signaling in some people.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal part of being human and are common in the general population. Most do not have a direct effect on health and are simply part of natural human variation. For many genes, having a variant linked to a condition suggests a possible association rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For people living with multicentric Castleman disease, treatment often needs to be tailored, because the illness can act very differently from one person to the next. In most cases, doctors do not use inherited genetic testing to choose the standard medicines used for multicentric Castleman disease. Instead, the best treatment for multicentric Castleman disease is guided mainly by the subtype, whether HHV-8 infection is present, and how strongly the immune system is driving inflammation, which helps explain why some people receive a drug that blocks IL-6, such as siltuximab, while others may need rituximab, steroids, or chemotherapy. Not every difference in response is genetic, but researchers are studying changes in immune pathways and in affected cells to understand why some treatments work better for some people than for others. Right now, those findings are not part of routine pharmacogenetic testing for multicentric Castleman disease. For many, this means treatment is adjusted over time based on symptoms, blood tests, and side effects rather than on a single DNA result.
Interactions with other conditions
People living with multicentric Castleman disease can become much sicker when they also have infections, autoimmune conditions, or a weakened immune system. This matters in daily life because a fever, swollen lymph nodes, tiredness, or fluid buildup may be hard to sort out when another illness is happening at the same time. Doctors call it a comorbidity when two conditions occur together. Multicentric Castleman disease is especially important to assess alongside HIV, and in some people it is linked with HHV-8, a virus that can also raise the risk of illnesses such as Kaposi sarcoma. Many living with multicentric Castleman disease may also have low blood counts, liver or kidney strain, or nerve symptoms, and these problems can overlap with other inflammatory or blood-related disorders. Because the early symptoms of multicentric Castleman disease can look like infection, autoimmune disease, or even some cancers, careful testing is often needed so treatment is aimed at the right cause. Talk with your doctor about how your conditions may influence each other.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Multicentric castleman disease?
Other illnesses can look a lot like multicentric Castleman disease, especially lymphoma, which is a cancer of the lymph nodes, because both can cause swollen lymph nodes, fever, night sweats, weight loss, and tiredness. Some serious infections, including HIV and tuberculosis, can also cause similar whole-body symptoms and enlarged lymph nodes. Doctors may also need to rule out immune system illnesses such as lupus, because they can cause ongoing inflammation and make many people feel unwell in similar ways.
History
For many people living with multicentric Castleman disease, the hardest part early on was that it did not fit neatly into one familiar illness. Someone might have swollen glands, fevers, night sweats, or deep fatigue, yet the usual explanations did not fully add up. That uncertainty shaped the early history of multicentric Castleman disease as much as the disease itself.
The story began in the 1950s, when doctors described an unusual pattern in lymph nodes, the small immune glands found throughout the body. These early reports were mostly about a single enlarged lymph node or one area of enlarged nodes, which is now understood as a different form of Castleman disease. Over time, doctors realized that some people had a broader illness, with enlarged lymph nodes in several parts of the body along with whole-body symptoms such as fever, weight loss, weakness, and fluid buildup.
By the 1970s and 1980s, this wider-reaching form came to be recognized as multicentric Castleman disease. That mattered because it helped separate people with a local lymph node problem from those with an illness affecting the immune system more broadly. This was a major step, since treatment needs and outlook can be very different.
As medical science evolved, researchers also learned that multicentric Castleman disease is not just one single pathway of illness. Some cases were later linked to viral infection, especially in people with weakened immune systems, while others were found to happen without that same trigger. This helped explain why symptoms, test results, and response to treatment could vary so much from one person to another.
In recent decades, awareness has grown, and that has improved both diagnosis and care. Better imaging, more careful lymph node testing, and a clearer understanding of inflammatory signals in the immune system have all helped doctors recognize the condition earlier. Many living with multicentric Castleman disease today benefit from a much more precise approach than was possible in the past.
That said, the condition can still be challenging to spot because the early symptoms of multicentric Castleman disease can look like infection, autoimmune illness, or even some cancers. Looking back at its history helps explain why diagnosis sometimes takes time: doctors first had to learn that under the name Castleman disease, there were actually different patterns of illness. That clearer picture has made today’s care more informed, and in many cases, more effective.